Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes

Fig. 2

Univariate sensitivity analysis of the a targeted age-group of vaccination, and b the uptake rate in healthy children. The cost-effectiveness plane contains the incremental costs and quality-adjusted life-years (QALYs) of adding the childhood program to the current program (CP). The colored dots represent the average outcome, and the contour line represents the 95% interval of the simulations. The gray line indicates the conventional Dutch cost-effectiveness threshold of €20,000 per QALY gained

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us